← All companies

ECOC

ABVC BIOPHARMA, INC.

ECOC Nasdaq Pharmaceutical Preparations EDGAR ↗

—

—

Key statistics

from XBRL data in SEC filings

Market cap ⓘ

—

Revenue (TTM) ⓘ

$296K

Net income (TTM) ⓘ

-$7.11M

EPS (TTM) ⓘ

$-0.29

P/E ratio ⓘ

—

Dividend yield ⓘ

—

Free cash flow ⓘ

-$3.01M

Cash ⓘ

$31.9K

Total assets ⓘ

$19.4M

Gross margin ⓘ

171.9%

52-week range ⓘ

—

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Entered a material agreement; Completed an acquisition or disposition; Regulation FD disclosure Aug 27, 2026

10-Q Quarter ended 2026-06-30 Aug 12, 2026

8-K/A Other events Aug 12, 2026

8-K Other events Aug 4, 2026

8-K Changed accountants Jul 2, 2026

10-Q Quarter ended 2026-03-31 May 18, 2026

8-K Shareholder vote results Mar 27, 2026

10-K Fiscal year ended 2025-12-31 Mar 3, 2026

10-Q/A Quarter ended 2025-09-30 Mar 3, 2026

8-K Results of operations (earnings release); Previously issued financials not reliable Mar 3, 2026

8-K/A Unregistered sale of equity Jan 16, 2026

8-K Results of operations (earnings release) Nov 3, 2025

10-Q Quarter ended 2025-09-30 Nov 3, 2025

8-K Director or officer change Oct 30, 2025

8-K/A Changed accountants Sep 12, 2025

8-K Results of operations (earnings release) Aug 14, 2025

10-Q Quarter ended 2025-06-30 Aug 13, 2025

8-K/A Entered a material agreement; Unregistered sale of equity Jul 18, 2025

8-K Shareholder vote results Jun 4, 2025

8-K/A Unregistered sale of equity May 30, 2025

8-K/A Unregistered sale of equity May 14, 2025

8-K/A Delisting notice or listing-rule failure; Regulation FD disclosure May 14, 2025

8-K/A Delisting notice or listing-rule failure May 6, 2025

8-K/A Previously issued financials not reliable May 2, 2025

8-K Results of operations (earnings release) May 1, 2025

10-Q Quarter ended 2025-03-31 Apr 30, 2025

8-K Delisting notice or listing-rule failure; Unregistered sale of equity Apr 30, 2025

8-K/A Results of operations (earnings release); Regulation FD disclosure Apr 16, 2025

8-K Results of operations (earnings release); Previously issued financials not reliable; Regulation FD disclosure Apr 15, 2025

10-K Fiscal year ended 2024-12-31 Apr 15, 2025

8-K Director or officer change Mar 7, 2025

8-K/A Delisting notice or listing-rule failure; Regulation FD disclosure Jan 13, 2025

8-K Entered a material agreement; Unregistered sale of equity Jan 6, 2025

8-K Results of operations (earnings release) Nov 14, 2024

10-Q Quarter ended 2024-09-30 Nov 14, 2024

8-K Entered a material agreement; Unregistered sale of equity Nov 4, 2024

8-K Changed accountants Oct 18, 2024

8-K Other events Sep 10, 2024

8-K Regulation FD disclosure Aug 20, 2024

8-K Results of operations (earnings release) Aug 15, 2024